from the when-matter-becomes-software dept.
engeneOS in Cambridge, MA states in a press release: "The company is developing Engineered Genomic Operating Systems to enable the design and construction of programmable Biomolecular Machines employing natural and artificial building blocks. These Biomolecular Machines will serve a broad range of commercial applications including biosensors, chemical synthesis and processing, bio-electronic devices and materials, nanotechnology [emphasis added]…" CP: The team list is impressive.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.